Steve Targum
Scientific Director
Signant Health

Dr Targum is widely regarded as an expert in the areas of protocol design, clinical trial methodologies, surveillance strategies, study analysis, and the progression of new drug candidates from concept to approval to launch.He has been a Principal Investigator in over 200 company-sponsored clinical trials and has published over 150 scientific articles in the areas of psychopharmacology, psychobiology, and clinical trials methodology.
Dr Targum received his BA in biology from Colgate University and an MD from Mount Sinai School of Medicine. He was Professor of Psychiatry and Vice-Chairman of the Department of Mental Health Sciences at Hahnemann University School of Medicine (Philadelphia) from 1989-1995 and a consultant in psychiatry at the Massachusetts General Hospital in Boston, Massachusetts from 2005-2014. Dr Targum was also an executive in residence at Oxford BioScience Partners, a venture capital firm from 2005-2011.